致敬JF Normant教授,他是一位杰出的科学家和一个出色的人,并表彰他在有机金属化学领域的杰出成就。 抽象的 研究了各种代表性的铜(I)交换沸石在Chan-Lam交叉偶联反应中的催化潜力。Cu I -USY似乎是最好的催化剂,并被证明可以在有吸引力,简单和实用的条件下有效地促进C–N交叉偶联过程,即在空气中在无碱的情况下在甲醇中回流。 研究了各种代表性的铜(I)交换沸石在Chan-Lam交叉偶联反应中的催化潜力。Cu I -USY似乎是最好的催化剂,并被证明可以在有吸引力,简单和实用的条件下有效地促进C–N交叉偶联过程,即在空气中在无碱的情况下在甲醇中回流。
3,5-Dibromophenyl-functionalised imidazolium salts and their corresponding [Au(NHC)2]+ complexes: synthesis, supramolecular chemistry and anti-cancer activity
作者:Hawraa S. Al-Buthabhak、Yu Yu、Alexandre Sobolev、Hani Al-Salami、Murray V. Baker
DOI:10.1007/s10847-021-01082-6
日期:2021.12
The synthesis and spectroscopic and structural characterisation of new 3,5-dibromophenyl-functionalised imidazoliumsalts and their corresponding [Au(NHC)2]+ complexes is reported. X-ray diffraction studies revealed intra- and intermolecular interactions involving the 3,5-dibromophenyl group, including Br…π interactions with imidazolyl and C6 arene rings. Au-NHC complexes functionalised with 3,5-dibromophenyl
Disclosed are Carbapenem antibacterial agents of the formula
and intermediates for making them.
公开了式中的碳青霉烯类抗菌剂
及其中间体。
US5276149A
申请人:——
公开号:US5276149A
公开(公告)日:1994-01-04
[EN] IMIDAZOQUINOXALINE PROTEIN TYROSINE KINASE INHIBITORS<br/>[FR] INHIBITEURS A BASE D'IMIDAZOQUINOXALINES DE LA PROTEINE TYROSINE KINASE
申请人:BRISTOL-MYERS SQUIBB COMPANY
公开号:WO1999009845A1
公开(公告)日:1999-03-04
(EN) Novel imidazoquinoxalines and salts thereof, pharmaceutical compositions containing such compounds, and methods of using such compounds in the treatment of protein tyrosine kinase-associated disorders such as immunologic disorders.(FR) La présente invention concerne de nouvelles imidazoquinoxalines et des sels de celles-ci, des compositions pharmaceutiques contenant ces composés et des procédés d'utilisation de ces composés dans le traitement de troubles associés à la protéine tyrosine kinase, tels que des troubles immunologiques.
2-(N-imidazoliumphenyl)-carbapenems
申请人:Merck & Co., Inc.
公开号:US05276149A1
公开(公告)日:1994-01-04
Carbapenems of the formula ##STR1## are useful antibacterial agents.